HolderBook

Dauntless Investment Group, LLC

Reported holdings as of Q2 2026, from 7 quarterly filings.

CIK
2044285
Reported value
$127.3M
Positions
73
Top 10 weight
72.4%
Filed
2026-08-13
Days after quarter end
44

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
ISHARES TR OPTIWM$36.1Moptions only28.33%+23.66pp2qOPTIONS
INVESCO QQQ TR OPTQQQ$12.0Moptions only9.43%-newOPTIONS
ELECTRONIC ARTS INC OPTEA$9.4Moptions only7.41%-newOPTIONS
AEON BIOPHARMA INCAEON$9.0M12,490,1547.06%+5.41pp6q+394.1%+$7.2M
FEMASYS INC$7.8M1,867,9876.13%-newNEW
KAZIA THERAPEUTICS LTDKZIA$5.0M354,2083.92%+3.53pp5q+343.7%+$3.9M
VANECK ETF TRUST OPTSMH$4.7Moptions only3.66%-newOPTIONS
SPDR SERIES TRUST OPTXBI$3.2Moptions only2.49%-newOPTIONS
VALERO ENERGY CORPVLO$2.8M10,6202.17%-newNEW
ST JOE COJOE$2.3M36,1671.78%+0.44pp7q+12.1%+$245.1K
ADAGENE INCADAG$2.3M537,2301.77%+1.68pp2q+1444.9%+$2.1M
ESTABLISHMENT LABS HLDGS INCESTA$2.2M25,7281.73%+1.38pp3q+172.9%+$1.4M
IRSA INVERSIONES Y REP S AIRS$2.0M126,5421.54%-newNEW
AZITRA INCAZTR$1.9M11,292,1861.49%+1.49pp2q+1129118.6%+$1.9M
LINCOLN EDL SVCS CORPLINC$1.5M31,0461.22%-0.38pp7q-47.8%-$1.4M
TIZIANA LIFE SCIENCES LTDTLSA$1.5M1,162,0001.17%-0.51pp6q-46.3%-$1.3M
PROFOUND MED CORPPROF$1.4M208,3691.09%+0.06pp3q-13.4%-$215.3K
ARMATA PHARMACEUTICALS INCARMP$1.3M203,8911.04%+0.42pp3q+125.1%+$734.3K
LOMA NEGRA CORPLOMA$1.3M115,1861.04%-newNEW
COURSERA INCCOUR$1.3M224,1710.99%-0.60pp6q+154.2%+$767.0K
ALPHABET INC OPTGOOG$1.2Moptions only0.97%-newOPTIONS
UNIVERSAL TECHNICAL INST INCUTI$1.2M27,9900.94%+0.59pp3q+92.0%+$573.5K
AMAZON COM INC OPTAMZN$1.0Moptions only0.82%-newOPTIONS
MICROSOFT CORP OPTMSFT$1.0Moptions only0.82%-newOPTIONS
QUOIN PHARMACEUTICALS LTDQNRX$1.0M214,9870.82%-0.04pp2q+9.4%+$89.0K
SERVICENOW INCNOW$1.0M10,2000.80%-newNEW
UNICYCIVE THERAPEUTICS INCUNCY$1.0M214,0000.79%+0.15pp3q+45.5%+$313.8K
META PLATFORMS INC OPTMETA$957.6Koptions only0.75%-newOPTIONS
CRESUD S A C I F Y ACRESY$898.9K80,1860.71%-newNEW
THE ONCOLOGY INSTITUTE INCTOI$888.2K163,5700.70%-0.24pp2q-64.6%-$1.6M
PTC THERAPEUTICS INCPTCT$831.4K10,1930.65%+0.28pp3q+21.9%+$149.4K
ALPHA TAU MEDICAL LTDDRTS$769.9K61,2000.60%-newNEW
TALPHERA INCTLPH$768.4K746,0510.60%+0.39pp4q+71.4%+$320.1K
CHURCHILL CAP CORP XICCXI$673.3K38,5870.53%-newNEW
MAREX GROUP PLCMRX$629.2K10,3240.49%-0.11pp3q-49.2%-$609.4K
MARATHON PETE CORPMPC$578.8K2,2640.45%-0.22pp4q-45.5%-$483.7K
UPWORK INCUPWK$565.8K67,6800.44%-newNEW
NEURONETICS INCSTIM$479.9K369,1870.38%+0.12pp3q+37.1%+$130.0K
COGNITION THERAPEUTICS INCCGTX$427.5K371,7010.34%+0.12pp3q-13.8%-$68.2K
PILGRIMS PRIDE CORPPPC$385.7K13,7210.30%-0.48pp2q-56.3%-$496.5K
MAUI LD & PINEAPPLE INCMLP$344.3K19,3620.27%+0.22pp5q+258.8%+$248.3K
AIRSCULPT TECHNOLOGIES INCAIRS$303.1K67,3600.24%+0.24pp2q+6735900.0%+$303.1K
GRUPO FINANCIERO GALICIA S.AGGAL$211.1K4,2200.17%-newNEW
CAL MAINE FOODS INCCALM$207.9K2,5810.16%-0.58pp2q-81.9%-$938.2K
MOBILICOM LTDMOB$144.9K28,2450.11%-newNEW
SONIDA SENIOR LIVING INCSNDA$143.7K3,5210.11%-newNEW
WELLTOWER INCWELL$140.5K6190.11%-newNEW
APYX MEDICAL CORPORATIONAPYX$135.8K30,2490.11%-newNEW
BROOKDALE SR LIVING INCBKD$73.5K4,5710.06%-newNEW
JANUS LIVING INCJAN$68.9K2,3980.05%-newNEW
TRAWS PHARMA INCTRAW$67.9K80,5740.05%-0.45pp2q-80.7%-$283.7K
ERNEXA THERAPEUTICS INC$39.9K6,0000.03%-newNEW
INNOVIVA INCINVA$36.8K1,6200.03%-1.86pp3q-98.7%-$2.7M
GRUPO CIBEST SACIB$35.2K4430.03%-newNEW
AGNICO EAGLE MINES LTDAEM$25.6K1650.02%-0.02pp7q-39.3%-$16.6K
GLOBAL X FDSCOLO$21.1K5070.02%-newNEW
HESAI GROUPHSAI$20.0K1,1000.02%-newNEW
RENATUS TACTICAL ACQUISRTAC$19.0K1,8130.01%flat5qHELD
TEXAS VENTURES ACQUISITION ITVA$8.5K8050.01%-0.02pp4q-80.0%-$33.9K
JBS N.V.JBS$8.0K6740.01%-0.25pp5q-96.8%-$244.5K
AMERICAN EXCEPTIONALISM ACQUAEXA$7.9K6700.01%flat3qHELD
CURIS INCCRISXXXX$5.2K10,0010.00%-0.24pp2q-98.5%-$338.7K
DOUBLELINE INCOME SOLUTIONSDSL$3.6K3260.00%flat5qHELD
ABRDN PLATINUM ETF TRUSTPPLT$3.4K2400.00%flat7q+900.0%+$3.1K
DAKOTA GOLD CORPDC$2.5K5810.00%-0.23pp2q-99.2%-$291.6K
NEW AMER ACQUISITION I CORPNWAXU$1.8K1720.00%flat3qHELD
POWELL INDS INCPOWL$28610.00%-newNEW
INMUNE BIO INCINMB$1631000.00%-0.14pp3q-99.9%-$298.9K
LINEAGE CELL THERAPEUTICS INLCTX$1311000.00%-newNEW
CAPRICOR THERAPEUTICS INCCAPR$2410.00%-0.28pp2q-100.0%-$337.7K
TREVI THERAPEUTICS INCTRVI$1910.00%-newNEW
HALL CHADWICK ACQUISITION COHCAC$1010.00%-newNEW
NORTHERN DYNASTY MINERALS LTNAK$210.00%flat7qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 19.7%Software & IT Services 12.2%Funds & ETFs 9.4%Real Estate 4.5%Medical Devices 3.9%Energy 2.6%Business Services 2.2%Other sectors 4.8%Not classified 40.7%
 
SectorValueShare
Biotech & Pharma$25.1M19.7%
Software & IT Services$15.5M12.2%
Funds & ETFs$12.0M9.4%
Real Estate$5.7M4.5%
Medical Devices$5.0M3.9%
Energy$3.3M2.6%
Business Services$2.7M2.2%
Other sectors$6.2M4.8%
Not classified$51.8M40.7%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$127.3M733217182772.4%44
Q1 2026$151.0M682912222781.2%44
Q4 2025$125.9M662613122578.0%48
Q3 2025$160.0M653612113967.8%45
Q2 2025$57.5M68368202272.3%45
Q1 2025$85.4M54303113671.4%37
Q4 2024$95.1M60000076.2%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.